Bonqat is a drug owned by ORION CORP. It is protected by 1 US drug patent filed in 2043. All patents are active. Details of Bonqat’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US12558331 | Active | |
Exclusivity Information
Bonqat holds 1 exclusivity out of which 0 have expired. Its last outstanding exclusivity is set to expire in 2028. Details of Bonqat's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCE | Nov 17, 2028 |
About Bonqat
Bonqat is a drug
owned by ORION CORP.
Bonqat uses
Pregabalin as the active
ingredient.
Active Ingredient:
Bonqat uses
Pregabalin as the active ingredient.
Check out other Drugs and Companies using
Pregabalin ingredient.